IART
Integra LifeSciences Holdings Corporation
Medical Devices · Healthcare · United States
12.83
close · 2026-10-29
value
96
cheaper than peers96
quality
37
stronger fundamentals37
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 5.37× | 96 |
| price to sales | 0.56× | 89 |
| price to book | 0.94× | 86 |
| EV to EBITDA | 8.88× | 82 |
4 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 9.6% | 76 |
| return on equity | -0.7% | 64 |
| revenue growth | 0.8% | 27 |
| debt to equity | 196.5% | 17 |
4 of 4 measures available
Facts
| market cap | $998M |
| free cash flow | $94.4M |
| employees | 4,427 |
| first trade | 1995-08-16 |
| next earnings | 2026-10-21 |
| fundamentals updated | 2026-10-21 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -6.74 | -0.09 | 0.84 | 2.16 |
| free cash flow | -$45.3M | $15.0M | $73.1M | $217.4M |
| net income | -$516.5M | -$6.9M | $67.7M | $180.6M |
| revenue | $1.64B | $1.61B | $1.54B | $1.56B |
| unusual items | -$511.4M | $0 | $0 | $644,000 |